Natural Killer Cells Therapies

1. Natural Killer Cells Therapies

2. Summary “Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017”, emphasizes on the currently active NK cell therapy products and NK cell augmenters in research and development. The report covers 20+ companies, which are active in this field with 40+ products and many different technologies. This report covers NK cell based therapies and drugs that augment (enhance or activate) the NK cells. The report provides in-depth analysis on the Natural Killer Cell based therapies profiles along with the augmenting therapies covering their pre-clinical and clinical studies, collaborations details and deal values, technologies and targeted antigens. The report provides the NK Cell based therapies licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis.

4. Reports Highlights: - NK cell Therapy Pipeline scenario which includes NK cell therapies and NK cell augmenting therapies. - Collaborations & partnering deals - Current Prominent Research Areas and Key Players - Pipeline product profiles NK Cell therapy Technologies and NK cell Augmenting Therapies - Licensing opportunities - Market Drivers and Barriers

5. Scope • Overview of the global NK cell therapy and NK cell augmenting therapies pipeline scenario, products and associated companies information • Coverage of global NK cell therapies and drugs that enhance the activity of NK under development • Competitive landscape of products for key players and related indications • Coverage of licensors, collaborators and development partners, deal terms and deal values estimation • Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities • Highlights of licensing & collaboration opportunities and funding details • Highlights of latest NK cell therapy technologies and NK cell augmenting therapies and innovative companies • Key topics covered include strategic competitor assessment, barriers and drivers in the market along with SWOT analysis

6. Table of Contents • Executive Summary • Market Barriers • Natural Killer Cells Based Therapies and Targets • Collaborations and Deal value • Pipeline Therapeutics for Natural Killer Cells Based Therapies • Comparative Analysis • Therapeutic Assessment of Natural Killer Cell Therapies • Assessment by Stage and Route of Administration • Targets of Natural Killer Cells Augmenters and Their Analysis • Companies received Grants for NK cells augmenters based therapies • Pipeline Therapeutics for Natural Killer Cells Augmenters(Enhancers & Activators) • Therapeutic Assessment of Natural Killer Cell Augmenters (Enhancers & Activators) • Appendix

7. Full Reports Natural Killer Cells Therapies

8. THANK YOU